A Clinical Trial Evaluating Injection of TQB6411 in Subjects With Advanced Malignant Tumors | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
A Clinical Trial Evaluating Injection of TQB6411 in Subjects With Advanced Malignant Tumors	Advanced Malignant Tumors	Recruiting	Phase 1	2026-01-21		NCT07043751

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.	32

19 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
AnYang Tumor Hospital	Anyang	China	3
Beijing Friendship Hospital, Capital Medical University	Beijing	China	64
Dongguan People's Hospital	Dongguan	China	8
Fudan University Shanghai Cancer Center	Shanghai	China	257
Guangdong Provincial People's Hospital	Guangzhou	China	6
Jiangsu Province Hospital	Nanjing	China	89
Jining First People's Hospital	Jining	China	2
Mianyang Central Hospital	Mianyang	China	11
Shanghai Jiaotong University School of Medicine, Renji Hospital	Shanghai	China	1
ShangHai Pulmonary Hospital	Shanghai	China	11
Sichuan Cancer Hospital	Chengdu	China	46
The First Affiliated Hospital of Zhengzhou University	Zhengzhou	China	125
The First Hospital of China Medical University	Shenyang	China	16
The Henan Cancer Hospital	Zhengzhou	China	1
The Second Xiangya Hospital of Central South University	Changsha	China	67
Tianjin Medical University Cancer Institute & Hospital	Tianjin	China	58
West China Hospital, Sichuan University	Chengdu	China	129
Zhongnan Hospital of Wuhan University	Wuhan	China	65
ZhuJiang Hospital of Southern Medical University	Guangdong	China	1